JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

Strona główna・Stock List・PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corp

Closed

SectorHealthcare

33.7 -2.15

Buy Sell

Overview

Share price change

24h

Current

Min

33.7

Max

34.21

Key metrics
By Trading Economics
Income	5.2M -20M
Sales	10M 79M
Profit margin	-24.727
Employees	756
EBITDA	-1.3M -24M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+82.6% upside

Dividends
By Dow Jones
Next Earnings	4 lis 2025

Market Stats
By TradingEconomics
Market Cap	-722M 2B
Previous open	35.85
Previous close	33.7

News Sentiment

By Acuity

50%

142 / 373 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

52.655 / 56.31 Support & Resistance

PROCEPT BioRobotics Corp Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

2 lis 2025, 22:13 UTC

Earnings

Westpac Raises Dividend Despite 1% Slip in Annual Profit -- Update

2 lis 2025, 21:23 UTC

Earnings

Westpac Raises Dividend Despite 1% Slip in Annual Profit

2 lis 2025, 23:43 UTC

Market Talk

Gold Falls on Reports of China's Finance Ministry Ending Tax Incentive for Gold Sales -- Market Talk

2 lis 2025, 23:34 UTC

Market Talk

Oil Rises as OPEC+ Signals Output-Increase Pause -- Market Talk

2 lis 2025, 21:00 UTC

Earnings

Westpac Has Set Tech Overhaul Goals and Will Share Progress, CEO Says>WBC.AU

2 lis 2025, 21:00 UTC

Earnings

Westpac Is Now Executing on Tech Overhaul, CEO Says>WBC.AU

2 lis 2025, 21:00 UTC

Earnings

Westpac Has Completed Tech Overhaul's Discovery and Planning Phases, CEO Says >WBC.AU

2 lis 2025, 20:55 UTC

Earnings

Westpac FY Australia Mortgage Lending Up 5% on Year>WBC.AU

2 lis 2025, 20:55 UTC

Earnings

Westpac FY Institutional Lending Up 17% on Year>WBC.AU

2 lis 2025, 20:55 UTC

Earnings

Westpac FY Business Lending Up 15% on Year>WBC.AU

2 lis 2025, 20:46 UTC

Earnings

Westpac Expects Completion in 2H of FY 2026>WBC.AU

2 lis 2025, 20:46 UTC

Earnings

Westpac Expects CET1 Capital Ratio to Rise by 20 Basis Points>WBC.AU

2 lis 2025, 20:45 UTC

Earnings

Westpac: Sale Is at Slight Premium to Expected Gross Loan Value at Completion>WBC.AU

2 lis 2025, 20:44 UTC

Earnings

Westpac Selling to Consortium Including KKR, Pimco and Pepper Money>WBC.AU

2 lis 2025, 20:43 UTC

Earnings

Westpac Agrees to Sell A$21.4B Rams Mortgage Portfolio>WBC.AU

2 lis 2025, 20:42 UTC

Earnings

Westpac FY Impairment Provisions A$4.99B Vs. A$5.10B>WBC.AU

2 lis 2025, 20:41 UTC

Earnings

Westpac FY Net Profit Ex-Notable Items A$7.0B, Down 2% on Year>WBC.AU

2 lis 2025, 20:40 UTC

Earnings

Westpac FY Customer Deposits A$723.0B Vs. A$673.6B>WBC.AU

2 lis 2025, 20:39 UTC

Earnings

Westpac FY Total Loans A$851.85B Vs. A$806.77B>WBC.AU

2 lis 2025, 20:37 UTC

Earnings

Westpac FY24 Impairment Charges 5 Bps of Loans Vs. 7 Bps in FY25>WBC.AU

2 lis 2025, 20:37 UTC

Earnings

Westpac FY Operating Expenses A$11.92B Vs. A$10.94B>WBC.AU

2 lis 2025, 20:37 UTC

Earnings

Westpac FY Non-Interest Income A$3.00B Vs. A$2.835B>WBC.AU

2 lis 2025, 20:36 UTC

Earnings

Westpac FY Net Interest Income A$19.38B Vs. A$18.75B>WBC.AU

2 lis 2025, 20:35 UTC

Earnings

Westpac FY CET1 Level 2 Capital Ratio 12.5% Vs. 12.5%>WBC.AU

2 lis 2025, 20:35 UTC

Earnings

Westpac FY Net Interest Margin 1.94% Vs. 1.95%>WBC.AU

2 lis 2025, 20:35 UTC

Earnings

Westpac Raises Dividend to A$0.77 Vs. A$0.76 >WBC.AU

2 lis 2025, 20:34 UTC

Earnings

Westpac FY Rev A$22.38B Vs. A$21.59B >WBC.AU

2 lis 2025, 20:33 UTC

Earnings

Westpac FY Net A$6.92B Vs. Net A$6.99B >WBC.AU

2 lis 2025, 14:27 UTC

Earnings

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

2 lis 2025, 14:25 UTC

Earnings

Warren Buffett Is Leaving Berkshire Hathaway in Great Shape for His Successor After Profit Results -- Barrons.com

Peer Comparison

Price change

PROCEPT BioRobotics Corp Forecast

Price Target

By TipRanks

82.6% upside

12 Months Forecast

Average 62.14 USD 82.6%

High 85 USD

Low 50 USD

Based on 9 Wall Street analysts offering 12 month price targets forPROCEPT BioRobotics Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

9 ratings

Buy

Hold

Sell

Based on 9 analysts giving stock ratings to PROCEPT BioRobotics Corp - Dist in the past 3 months.

Technical Score

By Trading Central

52.655 / 56.31Support & Resistance

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

All events are bearish.

Sentiment

By Acuity

142 / 373 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.